| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445257 | European Journal of Cancer | 2013 | 10 Pages |
Abstract
Adding cetuximab to FOLFIRI improved response rate and survival without either improving or negatively impacting on GHS/QoL and social functioning.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
István Láng, Claus-Henning Köhne, Gunnar Folprecht, Philippe Rougier, Desmond Curran, Erika Hitre, Ute Sartorius, Ingolf Griebsch, Eric Van Cutsem,